The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABBVIE INC | COM | 00287Y109 | 6,906 | 116,581 | SH | SOLE | 116,581 | 0 | 0 | ||
| ABEONA THERAPEUTICS INC | COM | 00289Y107 | 611 | 181,818 | SH | SOLE | 181,818 | 0 | 0 | ||
| ACHILLION PHARMACEUTICALS | COM | 00448Q201 | 2,552 | 236,500 | SH | SOLE | 236,500 | 0 | 0 | ||
| ADAPTIMMUNE THERAPEUTICS PLC | SPONDS ADR | 00653A107 | 580 | 48,100 | SH | SOLE | 48,100 | 0 | 0 | ||
| AERIE PHARMACEUTICALS INC | COM | 00771V108 | 3,613 | 148,369 | SH | SOLE | 148,369 | 0 | 0 | ||
| AKARI THERAPEUTICS PLC | SPONSORED ADR ADDED | 00972G108 | 121 | 8,341 | SH | SOLE | 8,341 | 0 | 0 | ||
| ALDER BIOPHARMACEUTICALS INC | COM | 014339105 | 595 | 18,000 | SH | SOLE | 18,000 | 0 | 0 | ||
| ANTARES PHARMA INC | COM | 036642106 | 54 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
| APPLIED GENETIC TECHNOL CORP | COM | 03820J100 | 3,207 | 157,192 | SH | SOLE | 157,192 | 0 | 0 | ||
| ARENA PHARMACEUTICALS INC | COM | 040047102 | 725 | 381,600 | SH | SOLE | 381,600 | 0 | 0 | ||
| ASCENDIS PHARMA | ADR ADDED | 04351P101 | 975 | 53,241 | SH | SOLE | 53,241 | 0 | 0 | ||
| ATRICURE INC | COM | 04963C209 | 10,950 | 487,946 | SH | SOLE | 487,946 | 0 | 0 | ||
| AVALANCHE BIOTECHNOLOGIES IN | COM | 05337G107 | 1,339 | 140,600 | SH | SOLE | 140,600 | 0 | 0 | ||
| BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 2,638 | 255,642 | SH | SOLE | 255,642 | 0 | 0 | ||
| BIOTELEMETRY INC | COM | 090672106 | 2,752 | 235,645 | SH | SOLE | 235,645 | 0 | 0 | ||
| BLUEBIRD BIO INC | COM | 09609G100 | 385 | 6,000 | SH | SOLE | 6,000 | 0 | 0 | ||
| CARA THERAPEUTICS INC | COM | 140755109 | 2,855 | 169,331 | SH | SOLE | 169,331 | 0 | 0 | ||
| CARDICA INC | COM | 14141R101 | 216 | 1,402,762 | SH | SOLE | 1,402,762 | 0 | 0 | ||
| CAREDX INC | COM | 14167L103 | 871 | 136,047 | SH | SOLE | 136,047 | 0 | 0 | ||
| CATALYST BIOSCIENCES INC | COM ADDED | 14888D109 | 222 | 70,903 | SH | SOLE | 70,903 | 0 | 0 | ||
| CEL SCI CORP | COM PAR $0.01 | 150837508 | 47 | 127,482 | SH | SOLE | 127,482 | 0 | 0 | ||
| CELYAD | ADR | 151205200 | 1,638 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
| CHECK CAP LTD | SHS ADDED | M2361E112 | 206 | 109,133 | SH | SOLE | 109,133 | 0 | 0 | ||
| CHECK CAP LTD | *W EXP 02/28/202 ADDED | M2361E120 | 38 | 53,763 | SH | SOLE | 53,763 | 0 | 0 | ||
| COGENTIX MEDICAL INC | COM | 19243A104 | 454 | 351,781 | SH | SOLE | 351,781 | 0 | 0 | ||
| CTI BIOPHARMA CORP | COM | 12648L106 | 3,930 | 3,195,381 | SH | SOLE | 3,195,381 | 0 | 0 | ||
| CYNAPSUS THERAPEUTICS INC | COM | 23257Y156 | 526 | 33,995 | SH | SOLE | 33,995 | 0 | 0 | ||
| CYNAPSUS THERAPEUTICS INC | COM PAR NO PAR | 23257Y859 | 694 | 44,824 | SH | SOLE | 44,824 | 0 | 0 | ||
| CYNAPSUS THERAPEUTICS INC | COM PAR NO PAR | 23257Y859 | 28 | 1,805 | SH | SOLE | 1,805 | 0 | 0 | ||
| CYTOKINETICS INC | COM NEW | 23282W605 | 418 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
| CYTRX CORP | COM PAR $.001 | 232828509 | 1,545 | 583,013 | SH | SOLE | 583,013 | 0 | 0 | ||
| DERMA SCIENCES INC | COM PAR $.01 | 249827502 | 1,616 | 353,718 | SH | SOLE | 353,718 | 0 | 0 | ||
| DICERNA PHARMACEUTICALS INC | COM | 253031108 | 1,432 | 120,600 | SH | SOLE | 120,600 | 0 | 0 | ||
| DISCOVERY LABORATORIES INC | COM NEW | 254668403 | 1,597 | 7,467,032 | SH | SOLE | 7,467,032 | 0 | 0 | ||
| ENDOLOGIX INC | NOTE 3.250%11/0 ADDED | 29266SAB2 | 545 | 500,000 | PRN | SOLE | 500,000 | 0 | 0 | ||
| ENTEROMEDICS INC | COM NEW | 29365M208 | 65 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| ESSA PHARMA INC | COM | 29668H104 | 1,045 | 228,500 | SH | SOLE | 228,500 | 0 | 0 | ||
| EXACTECH INC | COM | 30064E109 | 574 | 31,636 | SH | SOLE | 31,636 | 0 | 0 | ||
| FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 493 | 60,770 | SH | SOLE | 60,770 | 0 | 0 | ||
| GALAPAGOS NV | SPON ADR | 36315X101 | 1,886 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
| GALMED PHARMACEUTICALS LTD | SHS | M47238106 | 91 | 11,988 | SH | SOLE | 11,988 | 0 | 0 | ||
| GENVEC INC | COM NEW | 37246C307 | 176 | 95,800 | SH | SOLE | 95,800 | 0 | 0 | ||
| INSULET CORP | COM | 45784P101 | 4,009 | 106,018 | SH | SOLE | 106,018 | 0 | 0 | ||
| INSULET CORP | NOTE 2.000% 6/1 | 45784PAD3 | 2,512 | 2,407,000 | PRN | SOLE | 2,407,000 | 0 | 0 | ||
| INTEC PHARMA LTD JERUSALEM SHS | SHS ADDED | M53644106 | 639 | 119,296 | SH | SOLE | 119,296 | 0 | 0 | ||
| IRONWOOD PHARMA | NOTE 2.25% 15-Jun-2022 144A SR UNSECURED CONV | 46333XAC2 | 563 | 600,000 | PRN | SOLE | 600,000 | 0 | 0 | ||
| JOHNSON AND JOHNSON | COM | 478160104 | 966 | 9,400 | SH | SOLE | 9,400 | 0 | 0 | ||
| LIPOCINE INC | COM NEW | 53630X104 | 647 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| LOXO ONCOLOGY INC | COM | 548862101 | 1,756 | 61,737 | SH | SOLE | 61,737 | 0 | 0 | ||
| MACROGENICS INC | COM | 556099109 | 743 | 24,000 | SH | SOLE | 24,000 | 0 | 0 | ||
| MARINUS PHARMACEUTICALS INC | COM | 56854Q101 | 4,328 | 566,498 | SH | SOLE | 566,498 | 0 | 0 | ||
| MASIMO CORPORATION | COM | 574795100 | 1,910 | 46,010 | SH | SOLE | 46,010 | 0 | 0 | ||
| NEMUS BIOSCIENCE INC | COM | 64046J100 | 341 | 625,000 | SH | SOLE | 625,000 | 0 | 0 | ||
| NEOS THERAPEUTICS INC | COM ADDED | 64052L106 | 908 | 63,400 | SH | SOLE | 63,400 | 0 | 0 | ||
| NIVALIS THERAPEUTICS INC | COM | 65481J109 | 116 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
| NOVADAQ TECHNOLOGIES INC | COM | 66987G102 | 1,297 | 101,841 | SH | SOLE | 101,841 | 0 | 0 | ||
| NUVASIVE INC | NOTE 2.750% 7/0 | 670704AC9 | 1,045 | 760,000 | PRN | SOLE | 760,000 | 0 | 0 | ||
| NXSTAGE MEDICAL INC | COM | 67072V103 | 8,031 | 366,554 | SH | SOLE | 366,554 | 0 | 0 | ||
| PRONAI THERAPEUTICS INC | COM ADDED | 74346L101 | 150 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
| PROTALIX BIOTHERAPEUTICS INC | NOTE 4.500% 9/1 | 74365AAB7 | 1,775 | 2,500,000 | PRN | SOLE | 2,500,000 | 0 | 0 | ||
| REGULUS THERAPEUTICS INC | COM | 75915K101 | 785 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
| RIGEL PHARMACEUTICALS INC | COM NEW | 766559603 | 3,363 | 1,109,740 | SH | SOLE | 1,109,740 | 0 | 0 | ||
| SCYNEXIS INC | COM | 811292101 | 974 | 156,904 | SH | SOLE | 156,904 | 0 | 0 | ||
| SPECTRANETICS CORP | COM | 84760C107 | 1,202 | 79,812 | SH | SOLE | 79,812 | 0 | 0 | ||
| STEREOTAXIS INC | COM NEW | 85916J409 | 1,021 | 1,372,862 | SH | SOLE | 1,372,862 | 0 | 0 | ||
| SYNERGY PHARMACEUTICALS | COM | 871639308 | 1,670 | 294,563 | SH | SOLE | 294,563 | 0 | 0 | ||
| SYNERON MEDICAL LTD | ORD SHS | M87245102 | 663 | 85,947 | SH | SOLE | 85,947 | 0 | 0 | ||
| TANDEM DIABETES CARE INC | COM | 875372104 | 432 | 36,551 | SH | SOLE | 36,551 | 0 | 0 | ||
| TARGACEPT INC | NOTE 2/1 ADDED | 87611RAA6 | 531 | 530,821 | PRN | SOLE | 530,821 | 0 | 0 | ||
| TENAX THERAPEUTICS INC | COM | 88032L100 | 261 | 79,509 | SH | SOLE | 79,509 | 0 | 0 | ||
| TOBIRA THERAPEUTICS INC | COM | 88883P101 | 1,612 | 160,353 | SH | SOLE | 160,353 | 0 | 0 | ||
| TREVENA INC | COM | 89532E109 | 155 | 14,800 | SH | SOLE | 14,800 | 0 | 0 | ||
| UNIQURE B.V. | NV SHS | N90064101 | 579 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
| VENAXIS INC | COM | 92262A107 | 181 | 594,800 | SH | SOLE | 594,800 | 0 | 0 | ||
| VITAE PHARMACEUTICALS INC | COM | 92847N103 | 3,497 | 193,224 | SH | SOLE | 193,224 | 0 | 0 | ||
| VTV THERAPEUTICS INC | CL A ADDED | 918385105 | 497 | 73,000 | SH | SOLE | 73,000 | 0 | 0 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 786 | 97,730 | SH | SOLE | 97,730 | 0 | 0 | ||
| ZOGENIX INC | COM | 98978L204 | 1,023 | 69,400 | SH | SOLE | 69,400 | 0 | 0 | ||